MOLECULAR PHARMACOLOGY (USA) LTD.
CIK 0001191357
Revenue (TTM)
—
Q1 Nov 2014
Net Income (TTM)
−$112.49K
+44.3% YoY
Q1 Nov 2014
EPS Diluted (TTM)
—
Q1 Nov 2014
Gross Margin
—
Q1 Nov 2014
Operating Margin
—
Q1 Nov 2014
Net Margin
—
Q1 Nov 2014
Free Cash Flow (TTM)
—
Q1 Nov 2014
Cash
$1.52K
Q1 Nov 2014
Total Debt
—
Q1 Nov 2014
Shares Outstanding
111.55M sh
Q1 Nov 2014
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.